adivo Agreement
FyoniBio and adivo GmbH sign Service Agreement We are pleased to announce the signing of a Service Agreement with adivo covering the generation of a production cell line for their canine therapeutic mAb candidate. For the project, FyoniBio will use its versatile CHOnamite® cell line development platform, that integrates a high-performance Transposase technology and comprises […]
weiterlesen